
Pharmaceuticals & Chemicals · BSE
Incorporated in 2008, Sudarshan Pharma Industries Limited (SPIL) is a Mumbai-based company engaged in contract manufacturing, import, export, and supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and intermediates. The company sources and supplies generic formulations by outsourcing manufacturing facilities from domestic and international suppliers based on client requirements. Its products find applications across industries such as pharmaceuticals, paints, food, and adhesives. SPIL also supplies medicines and pharma formulations to hospitals, NGOs, government bodies, and healthcare institutions under its own brand, offering around 50 formulations in tablets, capsules, ointments, and injectables. With a strong sales and distribution network across five states, the company markets its products ethically in both Indian and international markets, while also offering formulation development, quality control, and customized pharma solutions.
Price Band
₹71 – ₹73
Issue Size
₹50.10 Cr
Lot Size
1600 shares
GMP
Est. Listing
₹73
at current GMP
Subscribed
1.06x
overall
Open
9 Mar 2023
Close
14 Mar 2023
Allotment
18 Mar 2023
Refund
19 Mar 2023
Demat Credit
20 Mar 2023
Listing
20 Mar 2023
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹73
Band: ₹71 – ₹73
Estimated Listing Price
₹73
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,16,800
Estimated Profit / Lot
₹0
1600 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹73 |
| 30 Oct 2026 | — | 0.0% | ₹73 |
| 29 Oct 2026 | — | 0.0% | ₹73 |
GMP is unofficial market data. Not a guarantee of listing performance.
Sudarshan Pharma Industries Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Chemicals sector with an aggregate issue size of ₹50.1 Crores. The shares are offered at a price band of ₹71 to ₹73 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,16,800 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-03-20, while un-allotted funds or UPI block mandates will be released on 2023-03-19.
The latest grey market premium for Sudarshan Pharma Industries Limited IPO is ₹0, which indicates an expected listing price of ₹73.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.